Niccolò Gori

19PUBLICATIONS
118CO-AUTHORS
PharmacogenomicsEpidemiological methodsAllergyNanotoxicology, health and safetyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 03, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.

Niccolò Gori, Lucia Di Nardo, Elena Ippoliti

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Sep 22, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.

Luca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci

|Aug 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.

Luca Potestio, Cataldo Patruno, Marika Del Gaudio

|Jul 28, 2025
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.

Antonella Loperfido, Claudio Montuori, Marco Caminati

|Jun 09, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

Edoardo Mortato, Niccolò Gori, Giacomo Caldarola

Pageof 4

Frequent Collaborators

10 joint publications

Andrea Chiricozzi

7 joint publications

Simone Ribero

6 joint publications

Ketty Peris

6 joint publications

Angelo Valerio Marzano